0001719789-19-000002.txt : 20191002
0001719789-19-000002.hdr.sgml : 20191002
20191002160839
ACCESSION NUMBER: 0001719789-19-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20191002
DATE AS OF CHANGE: 20191002
EFFECTIVENESS DATE: 20191002
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Meissa Vaccines Inc
CENTRAL INDEX KEY: 0001719789
IRS NUMBER: 471347172
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-350196
FILM NUMBER: 191132310
BUSINESS ADDRESS:
STREET 1: 329 OYSTER POINT BOULEVARD
STREET 2: 3RD FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-356-0494
MAIL ADDRESS:
STREET 1: 329 OYSTER POINT BOULEVARD
STREET 2: 3RD FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
D
1
primary_doc.xml
X0708
D
LIVE
0001719789
Meissa Vaccines Inc
329 OYSTER POINT BOULEVARD
3RD FLOOR
SOUTH SAN FRANCISCO
CA
CALIFORNIA
94080
650-356-0494
DELAWARE
None
None
Corporation
true
Martin
Moore
c/o Meissa Vaccines Incorporated
329 Oyster Point Boulevard, 3rd Floor
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Director
Kenneth
Kelley
c/o Meissa Vaccines Incorporated
329 Oyster Point Boulevard, 3rd Floor
South San Francisco
CA
CALIFORNIA
94080
Director
William
Daly
c/o Meissa Vaccines Incorporated
329 Oyster Point Boulevard, 3rd Floor
South San Francisco
CA
CALIFORNIA
94080
Director
Roderick
Tang
c/o Meissa Vaccines Incorporated
329 Oyster Point Boulevard, 3rd Floor
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Isaac
Cheng
c/o Meissa Vaccines Incorporated
329 Oyster Point Boulevard, 3rd Floor
South San Francisco
CA
CALIFORNIA
94080
Director
Stephanie
O?Brien
c/o Meissa Vaccines Incorporated
329 Oyster Point Boulevard, 3rd Floor
South San Francisco
CA
CALIFORNIA
94080
Director
Biotechnology
Decline to Disclose
- 06b
false
2019-09-17
false
true
true
Series A Preferred Stock and the Common Stock issuable upon conversion thereof.
false
0
33916581
13916583
19999998
false
37
0
0
0
false
Meissa Vaccines Inc
/s/ Martin Moore
Martin Moore
Chief Executive Officer
2019-10-02